MedTrace Logo

Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers

NCT01560702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-09-25

No results posted yet for this study

Summary

Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.

Conditions

  • Blood, Injection, Injury Type Phobia
  • Gastrointestinal Ulcer Haemorrhage
  • Adverse Reaction to Epinephrine

Interventions

DRUG

Epinephrine

10-30 cc of 1/10000 diluted epinephrine will be injected at edges of an actively bleeding ulcer.

BIOLOGICAL

Blood

5-20 cc autologous blood immediately withdrawn from the patient will be injected at edges of the actively bleeding ulcer.

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Mohamed H Emara, MD · Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01560702 on ClinicalTrials.gov